Sovuna Tablet, Film Coated
Product Images NDC 70954-804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sovuna (NDC 70954-804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Container-1 (Container 1)

Container-1 (Container 1)
This is a description for SOVUNA' hydroxychloroquine sulfate tablets. Each tablet contains 200 mg of hydroxychloroquine sulfate, which is equivalent to 155 mg of base. The medication is to be kept out of the reach of children. The tablets should be dispensed in a tight, light-resistant container. The FDA-approved dissolution test and acceptance criteria may differ from the USP. The tablets should be stored at room temperature between 20°C and 25°C (68°F and 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). The product is distributed by ANI Pharmaceuticals, Inc.*
FDA Label Image

Container-2 (Container 2)

Container-2 (Container 2)
Product Description: This is a pack of Sovuna tablets containing hydroxychloroquine sulfate. Each tablet has a strength of 200 mg and there are 100 tablets in total. The medication is aimed at treating a specific condition, however, the dosage information is not provided in this text. It is important to keep the tablets out of reach of children, as they can be particularly sensitive to the medication. The tablets should be stored in a tightly closed container that is resistant to light. The FDA-approved dissolution test and acceptance criterion differ from the USP. The tablets should be stored at room temperature, between 20°C and 25°C (68°F and 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). This product is distributed by ANI Pharmaceuticals, Inc.*
FDA Label Image

Container-3 (Container 3)

Container-3 (Container 3)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.